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Summary: Alloxan diabetes caused a marked stimulation of endogenous oxygen uptake by rat testis tissues. However,
the oxygen uptake in the presence of added glucose or pyruvate as substrate was significantly reduced. The ability
of the testis tissues to utilize these substrates and to produce lactate was significantly inhibited in the diabetic ani-
mals. Alloxan diabetes also increased the levels of cholesterol, cholesterol esters, non-esterified fatty acids, tri-
gjycerides and phospholipids in rat testis tissues. Treatment of the diabetic rats with ascorbic acid caused more or
less a normalization of all the parameters tested.
Die Wirkung von Ascorbinsäure auf Sauerstoffverbrauch, Glykolyse und Lipidstoffwechsel
diabetischer Ratten-Testes
Ascorbinsäure und Diabetes, 1. Mitteilung
Zusammenfassung: Alloxan^Diabetes fuhrt zu einer signifikanten Stimulation des endogenen Sauerstoffverbrauchs des
Testisgewebes der Ratte. Der Sauerstoffverbrauch wurde in Anwesenheit von Glucose und Pyruvat als Substrate
reduziert. Die Fähigkeit des Testisgewebes, diese Substrate zu verwenden und Lactat zu produzieren, wird in diabeti-
schen Tieren signifikant gehemmt. In Rattentestis haben Cholesterin, Cholesterinester, freie Fettsäuren, Triglyceride
und Phospholipide infolge des Alloxandiäbetes zugenommen. Durch Behandlung mit Ascorbinsäure wurden alle Para-
meter normalisiert.
Introduction
Alloxan diabetic effects on male reproduction in the
rat are characterized by a decrease in the testis weight
and degeneration of the tubular elements (1, 2), and
marked inhibition of spermatogenesis (3, 4).
Foglia (5) observed that fertility began to decline
shortly after alloxan treatment and reached negligible
level after 6 months. Similar changes were found in
male rats rendered diabetic by pancreatectomy (5, 6, 7).
An increased incidence of impotence (8, 9)j a decrease
in testis weight, and testjcular lesion at autopsy have
been reported in diabetic human males (10). In addition
semen quality, spermatozoa motility, fertility (11,12),
and sperm count (13) were depressed.
Deb & Chatterjee (14) have pointed out that testicular
degeneration and arrest of spermatogenesis in alloxan
diabetes were primarily due to lack of ascorbic acid in
the testis. A marked fall in plasma ascorbic acid level
and an increased urinary excretion of this acid has been
reported immediately after alloxan injection (15, 16)
or after subtotal pancreatectomy (17). These deleterious
effects caused by alloxan diabetes were corrected by
administration of high doses of ascorbic acid (14).
Although the histppathological appearance of alloxan
diabetic testis have received great attention, the effects
of ascorbic acid on many aspects of carbohydrate and
lipid metabolism of diabetic testis have not been fully
investigated. This stimulated our interest in the study
the effects of ascorbic acid on certain aspects of lipid
and carbohydrate metabolism in diabetic rat testis.
Materials and Methods
Young, male, mature albino rats (Sprague Dawly, Agoza strain)
weighing from 180-200 g were used. The animals were kept
under constant environmental and nutritional conditions. The
animals were rendered diabetic by a single i. p. injection of
15 Omg/kg alloxan (14).
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It is necessary to fast the animals 24 hours before alloxaniza-
tion. Each diabetic group was divided into two subgroups, one
of them received a daily treatment of ascorbic acid (1.5 g/kg
body weight) (14). This high dose of ascorbic acid was the
dose used by Deb & Chatterjee (14) to correct the degenerative
atrophy of the testis caused by alloxan diabetes.
After 3 weeks of treatment, both of the diabetic and diabetic
treated groups were sacrificed.
The diabetic state of the animals was confirmed by the deter-
mination of blood sugar 24 hours after alloxan injection and
weekly throughout the experimental period. The resistant
animals were discarded.
Tissue sampling
Immediately after killing the animals by decapitation the testis
were removed by dissection, blotted between two filter papers
and weighed.
Following dissection of tunica albuginca and blood vessels, the
tissue was placed on a watch glass chilled on ice and quickly
divided. One portion, about 200 mg of tissue was taken and
mixed with methanol for subsequent lipid extraction. The
remaining part was prepared for measurements of oxygen up-
take and other parameters of carbohydrate metabolism.
Carbohydrate metabolism
Oxygen uptake
120—150 mg fresh tissue was prepared by teasing apart the
tubules and transferred to Warburg flasks containing 3.7 ml of
phosphate buffer of pH 7.4 (18). The oxygen uptake was
measured by the direct method of Umbreit c. al. (19), in the
absence (endogenous oxygen uptake), or presence of substrates.
The substrates used were 12 mmol/1 glucose and 5.5 mmol/1
pyruvate. The readings of the manometers were recorded at
intervals of 10 minutes.
At the end of the experimental period (one hour) the tissues
were removed from the flasks, and the reaction was stopped by
addition of 0.2 ml 100 g/1 trichloroacetic acid. Centrifugation
was carried out for 10 minutes for deproteinization.
For measurement of substrate utilization and lactate produc-
tion, the difference in glucose or pyruvate concentration in the
supernatant fluid at the start and at the end of incubation was
calculated. Measurement of glucose was done according to the
method ofAsatoor & King (20), pyruvate by the method of
Friedmann & Haugen (21) and lactate by the method of Barker
& Summerson (22).
Extraction and analysis of lipid s
The total lipids were extracted according to the method of
Bligh & Dyer (23). An aliquot of lipid extract was taken for
direct total phosphoiipid determination (24, 25). Another
aliquot was used for neutral lipid fractionation. The fractiona-
tion was carried out by thin layer chromatography (26).
The system used was that of Muldner et al. (27) and was
composed of chloroform/methanol/water (volumes, 70 ml +
30 ml + 5 ml).
Visualization of the separated lipid spots was carried out by
exposure to iodine vapour.
After elution, the cholesterol and its esters (28), trigiycerides
(29) and nonesterified fatty acids (30) were measured.
All the chemicals were of analytical grade and purchased from
E. Merck AG (D-6100 Darmstadt) and BDH chemicals Ltd.
(Poole, England). All solvents used were freshly distilled before
use; ether was distilled over reduced iron. 2% methanol was
added to the distilled chloroform.
Results
In alloxan diabetic rats, the testis weight was markedly
reduced and reached about 40%, five weeks after
alloxanization. Treatment of the diabetic rats for
15 days after alloxanization with ascorbic acid increased
the weight of the testes, but they did not completely
return to the normal weight.
Carbohydrate metabolism
As shown in table 1 alloxan-diabetes caused a marked
stimulation of endogenous oxygen uptake of the testis
tissue, amounting to 33%. However, the Q 2 values of
the testis tissue were markedly reduced in the presence
of glucose or pyruvate as substrates. The ability of testis
tissue to utilize these substrates and to produce lactate
was significantly inhibited in animals rendered diabetic
with alloxan. Treatment with ascorbic acid caused a
complete normalization of all parameters tested.
Tab. 1. The effect of diabetes and diabetes treated with ascorbic acid on the testis weight, oxygen uptake (μΐ/h · g wet weight tissue)
in the absence or presence of glucose or pyruvate; glucose or pyruvate utilization arid lactate production of the rat testis tissues
(mg/g, wet weight tissue). Ascorbic acid was given daily in a dose of 1.5 g/kg body weight for three weeks. Values are expressed
as means ± S.E.M.
Testis weight Endogenous Oxygen uptake in presence of added substrates
Glucose (12mino,/,)
Control
Diabetic
Diabetic
treated with
ascorbic acid
(g)
2.23
±0.08
1.36*
±0.08
1.91**
±0.07
added
substrates)
(μΐ/h - g)
408
±20.3
545*
±20.3
399**
±23.83
Oxygen
uptake
(μΐ/h - g)
790
±36.7
459* '
± 18
703***
±23.4
Glucose
utilization
(mg/g)
19.97
±0.82
10.58*
±0.89
20.57**
±0.97
ο
Lactate
production
(mg/g)
3.38
±0.23
1.78*
±0.15
3.67**
±0.15
Pyruvate (5
Oxygen
uptake
(μΐ/h · g)
731
± 29.7
482*
±30
732**
± 18.8
.5 mmol/1)
Pyruvate
utilization
(mg/g)
6.95
±0.3
3.96*
±0.22
6.94**
±0.29
Lactate
production
(mg/g)
2.42
± 0.25
1.12*
±6.09
2.36**
±0.21
Values of each of control, diabetic and diabetic treated with ascorbic acid group are means of 12 male rats.
* Significantly different from the control (P < 0:05).
** Significantly different from the diabetic (P < 0.05).
*** Significantly different from both control and diabetic (P < 0.05).
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Tab. 2. The effects of diabetes and diabetes treated with ascorbic acid on the levels of total phospholipds, cholesterol, cholesterol
esters, total cholesterol, non-estcrified fatty acids, triglycerides and total lipids of the rat testis tissues. Values are expressed
in term of means (mg/g wet weight testis tissue) ± S.E.M. Ascorbic acid was given daily in a dose of 1.5 g/kg body weight for
three weeks.
Total phospholipids (mg/g)
Free cholesterol (mg/g)
Cholesterol esters (mg/g)
Total cholesterol (mg/g)
Non-esterified fatty acids (mg/g)
Triglycerides (mg/g)
Total lipids (mg/g)!!
Control
22.73 ±0.8
1.37 ±0.06
0.347 ± 0.02
1.7 ± 0.05
0.52 ±0.03
3.196 ± 0.10
28.15 ±0.86
Diabetic
35.59* ±0.68
1.72* ± 0.08
0.975* ± 0.05
2.57* ± 0.14
0.886* ± 0.04
4.73* ±0.12
43.77* ± 0.7
Diabetic treated
with ascorbic acid
25.41** ± 0.97
1.77* ±0.07
0.338** ±0.03
2.12*** ±0.09
0.658*** ± 0.03
3.455*** ±0.12
31.64*** ±0.95
The values of each of control, diabetic and diabetic treated with ascorbic acid group are means of 12 male rats.
* Significantly different from the control (P < 0.05)
** Significantly different from the diabetic (P < 0.05)
*** Significantly different from both control and diabetic (P < 0.05)
!! The sum of all lipid fractions studied.
Lipid pattern
Table 2 shows that alloxan diabetes produced a signifi-
cant rise in rat testicular phospholipids, reaching 56%.
Ascorbic acid treatment significantly reduced testicular
phospholipids of the diabetic rats, but the phospholipid
level was still higher than that of the control rats.
Alloxan diabetes also increased the levels of cholesterol,
cholesterol esters, non-esterified fatty acids, and tri-
glycerides, by 25%, 180%, 70% and 47% respectively.
Treatment of diabetic rats with ascorbic acid caused
more or less a normalization of all the lipid fractions
tested.
Discussion
Our results showed that alloxan diabetes markedly
reduced the rat testis weight and increased the rate of
endogenous oxygen uptake (in the absence of added
substrates). These data are in harmony with those
reported earlier (1, 2, 3, 4, 31, 32). The high rate of
endogenous respiration of these diabetic aspermatogenic
testes could be due to maintenance of the initial oxygen
uptake by endogenous substrates. From table 1 it is
clear that alloxan diabetes caused a marked reduction
in oxygen uptake when either glucose or pyruvate was
used as substrate. Furthermore the utilization of the
two substrates and the subsequent production of lactate
were also inhibited, these effects observed in the diabetic
testis might be attributed to one or more of the follow-
ing: a) loss of spermatocytes and spermatides, which are
the major sites of glucose metabolism (33), b) depression
of the key glycolytic enzymes resulting from lack of
insulin (34, 35), c) lack of ascorbic acid (14) and hence
inhibition of certain oxidoreductase enzymes in the
glycolytic and citric acid cycle pathways (36, 37, 38).
These results also indicated that diabetes may produce
certain changes in the permeability of the cell and
mitochondrial membranes and hence the penetration of
the exogenous substrates across these membranes.
This concept supports our findings that endogenous oxy-
gen uptake was reduced on addition of glucose or
pyruvate, but was stimulated when these substrates
were endogenously present within the cells.
These results revealed that treatment of the diabetic
rats with ascorbic acid caused more or less a normaliza-
tion of the studied parameters of carbohydrate meta-
bolism. This could be a reflection of the histological
appearance of mature glucose dependent germ cells in
the testis. The importance of ascorbic acid in carbo-
hydrate metabolism is mainly related to its reducing
property. Patterson et al (39) observed a decreased
level of glutathione in ascorbic acid deficient animals.
It is well known that the SH group is essential for a
number of enzymes catalyzing the glycolytic and"
citric acid cycle pathways (40, 41). Furthermore
BisWas&Deb (36) reported that succinate dehydrogen-
ase was inhibited in ascorbic acid deficient animals.
Thus administration of ascorbic acid to diabetic
animals would maintain a high level of the SH group,
which was claimed to be lowered by alloxan. Our
results showed that diabetes produced a significant rise
in all lipid fractions and consequently in the total
lipids of the testis. Such an increase could be attributed
to impaired development of germinal cells which
normally utilize these materials during active sper-
matogonesis as supplied by Sertoli cells (42,43, 44).
If it is accepted that testicular lipids arise from serum
fatty acids rather than from de novo synthesis within
the testis (45,46), the increase in total testicular lipids
may be due to increased uptake of fatty acids by the
testis in diabetic rats. This seems logical, as it has been
reported that in diabetic rats the multienzyme system
for acetate incorporation into free fatty acids was
markedly lower than the control ones (47,48,49). In
J. Clin. Chem. Clin. Biochem. / Vol. 16,1978 / No, 12
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addition the increment of certain esterified lipid
fractions could possibly be explained by an increased
rate of esterification of fatty acids to triglycerides,
cholesterol esters and phospholipids, since it has been
observed that lipids of rat testis show fatty acid in-
corporation characteristics (50, 51). Scott et al (52,
53) and Dawson & Scott (54) reported that phospho-
lipids serve as substrate for spermatozoa during their
development and maturation, therefore the rise in
total testicular phospholipids in alloxan diabetic rats
observed in this study could be explained by a
decreased rate of utilization of these compounds as a
result of germinal cell depletion (55).
The present investigation showed accumulation of
both cholesterol and cholesterol esters in the asperma-
togenic diabetic rat testis. This is supported by the
finding of Johnson et al (56). The accumulation could
result from a decreased rate of androgen biosynthesis,
since cholesterol esters are the normal precursor of
androgenic steroids (57, 58). Another factor that
contributes to the elevated level of cholesterol is the
increased de novo synthesis from acetyl-CoA. This is
in harmony with the finding that testis from rat actively
incorporated acetate into free and esterified cholesterol
(42).
In the present study, the persistent increased level of
non-esterified fatty acids and free cholesterol in the
testis of diabetic rat after treatment with ascorbic acid
indicates some defects in lipid metabolism. The treated
animals being still diabetic, may utilize some of the
non-esterified fatty acids that they take up, in addition
to glucose, for energy production. The significant drop
in phospholipid and triglyceride levels, in ascorbic acid
treated diabetic rats, may suggest that the incorporation
of long chain fatty acids into the two esterified fractions
goes at a comparable normal rate. In the testis of diabetic
animals the accumulated active acetate, resulting from
fatty acid oxidation, would find its way to both the
Krebs' cycle and to cholesterol synthesis, after treatment
with ascorbic acid, since the fatty acid synthetase system
is still inhibited due to lack of insulin (49). The non-
significant change of free cholesterol in the diabetic rat
from that in the testis of ascorbic acid treated animals
suggests that the cholesterol synthetase system is still
active, even after treatment with ascorbic acid, due to a
partial deficiency of insulin.
The considerable drop in cholesterol esters in the testes
of diabetic animals after ascorbic acid treatment is a
reflection of normalized steroidogenesis, since cholesterol
ester is the immediate precursor for testicular steroids
(57,58).
Finally it was concluded that diabetes seems to have
deleterious effects on the metabolic pathway of the
testis as on the other organs, for example liver. However,
ascorbic acid did not completely alleviate the ill effects
of diabetes in the testis; yet it is advisable to use this
vitamin together with the antidiabetic agents to poten-
tiate their good effects on the metabolic pathways in
this vital organ.
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